ArticleAnnals of clinical and translational neurology2026
Acoustic Measures Capture Speech Dysfunction in Spinocerebellar Ataxia.
Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveSpinocerebellar ataxias (SCA) are hereditary cerebellar degenerative disorders with a common feature of dysarthria, involving impaired phonatory and articulatory control of speech, thereby affecting social communication. In this study, we investigated whether acoustic measures could objectively measure speech dysfunction and identify common indicators across SCA types 1, 2, and 3.
methodsWe recorded speech from 24 SCA patients and 24 age-matched controls during connected speech and sustained vowel tasks. Speech was assessed using the Acoustic Voice Quality Index (AVQI) and sub-metrics (cepstral peak prominence smoothed [CPPS], harmonics-to-noise ratio [HNR], and shimmer). Jitter was used to quantify dysfunction in sustained vowels, and formant analysis was used to examine articulatory control. We also evaluated whether these measures capture speech dysfunction severity.
resultsAVQI was the most consistent indicator of speech dysfunction across SCA subgroups, showing a significant increase compared to controls. SCA patients exhibited abnormalities in AVQI sub-metrics (CPPS, HNR, and shimmer) and increased jitter during sustained vowels. Furthermore, formant analysis revealed articulation differences linked to changes in F2, F3, and F4 during connected speech, and F2 and F4 during sustained vowels. Additionally, AVQI correlates with the Scale for Assessment and Rating of Ataxia (SARA) speech sub-scores, whereas CPPS and jitter can differentiate between mild and moderate stages of ataxic speech.
conclusionOur findings show that SCA patients exhibit speech dysfunction across both connected speech and sustained vowel tasks, as AVQI stands out as a key indicator, whereas CPPS and jitter track ataxic speech severity. Our findings support using acoustic measures for objectively assessing speech dysfunction and thereby informing disease monitoring and guiding future targeted therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.